The aging worldwide population combined with rapidly revolutionary lifestyle treatments that revitalize youthfulness and stave off skin damage are the driving forces behind a healthy prescription dermatological drug market, which will see sales of $11.1 billion by 2010.

The data comes courtesy of a new study from market research firm Kalorama Information.

Mary Anne Crandall, RN says, "The aging population is better educated and wants to see results-whether they have wrinkles, skin cancer, or psoriasis. Today's consumers are savvy to innovative dermatological treatments, derma drug delivery developments, and new prescription drug information which is widely available on the Internet."

She continues, "This has changed the face of dermatology as cosmetic dermatology is now in vogue and manufacturers are racing to find new treatments to satiate public demand."

With 2005 sales reaching $8.4 billion, The Worldwide Market for Prescription Dermatological Drugs predicts that sales in the antiaging, photodamage, hair treatment, psoriasis, and skin cancer segments will grow further at a rate of 5.7% over the next four years as consumer demand for newer and better derma drugs continues to increase as the aging population struggles to deal with a variety of skin disorders and diseases.